{
    "root": "e9022492-18a7-44e1-9a89-45a4c06c72f1",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Mono-Linyah",
    "value": "20250120",
    "ingredients": [],
    "indications": "Mono-Linyah isÂ a combination of norgestimate, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy. ( 1.1 )",
    "contraindications": "Take one tablet daily by mouth at the same time every day (2.1) Take tablets in the order directed on the blister pack (2.1) Do not skip or delay tablet intake. (2.1)",
    "warningsAndPrecautions": "Mono-Linyah Tablets are available in a compact blister card (NDC 16714-360-01) containing 28 tablets in the following order: 21 blue, biconvex, round, coated tablets with \"C3\" debossed on one side containing 0.250 mg norgestimate and 0.035 mg ethinyl estradiol, and 7 white, biconvex, round, coated tablets with \"P\" debossed on one side and the \"N\" debossed on the other side containing inert ingredients.\n                        Mono-Linyah Tablets are available in the following configurations:\n                        Carton of 1 blister card NDC 16714-360-02\n                        Carton of 3 blister cards NDC 16714-360-03\n                        Carton of 6 blister cards NDC 16714-360-04",
    "adverseReactions": "A high risk of arterial or venous thrombotic diseases (4) Liver tumors or liver disease (4) Undiagnosed abnormal uterine bleeding (4) Breast cancer (4) Co-administration with Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir ( 4 )"
}